403 related articles for article (PubMed ID: 27924398)
1. A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria.
Hoppe B; Niaudet P; Salomon R; Harambat J; Hulton SA; Van't Hoff W; Moochhala SH; Deschênes G; Lindner E; Sjögren A; Cochat P
Pediatr Nephrol; 2017 May; 32(5):781-790. PubMed ID: 27924398
[TBL] [Abstract][Full Text] [Related]
2. A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria.
Milliner D; Hoppe B; Groothoff J
Urolithiasis; 2018 Aug; 46(4):313-323. PubMed ID: 28718073
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria.
Hoppe B; Groothoff JW; Hulton SA; Cochat P; Niaudet P; Kemper MJ; Deschênes G; Unwin R; Milliner D
Nephrol Dial Transplant; 2011 Nov; 26(11):3609-15. PubMed ID: 21460356
[TBL] [Abstract][Full Text] [Related]
4. Effects of Oxalobacter formigenes in subjects with primary hyperoxaluria Type 1 and end-stage renal disease: a Phase II study.
Hoppe B; Pellikka PA; Dehmel B; Banos A; Lindner E; Herberg U
Nephrol Dial Transplant; 2021 Jul; 36(8):1464-1473. PubMed ID: 32810261
[TBL] [Abstract][Full Text] [Related]
5. Oxalobacter formigenes treatment combined with intensive dialysis lowers plasma oxalate and halts disease progression in a patient with severe infantile oxalosis.
Pape L; Ahlenstiel-Grunow T; Birtel J; Krohne TU; Hoppe B
Pediatr Nephrol; 2020 Jun; 35(6):1121-1124. PubMed ID: 32107618
[TBL] [Abstract][Full Text] [Related]
6. ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria.
Ariceta G; Collard L; Abroug S; Moochhala SH; Gould E; Boussetta A; Ben Hmida M; De S; Hunley TE; Jarraya F; Fraga G; Banos A; Lindner E; Dehmel B; Schalk G
Pediatr Nephrol; 2023 Feb; 38(2):403-415. PubMed ID: 35552824
[TBL] [Abstract][Full Text] [Related]
7. Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1.
Hoppe B; Beck B; Gatter N; von Unruh G; Tischer A; Hesse A; Laube N; Kaul P; Sidhu H
Kidney Int; 2006 Oct; 70(7):1305-11. PubMed ID: 16850020
[TBL] [Abstract][Full Text] [Related]
8. Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis.
Hoppe B; Dittlich K; Fehrenbach H; Plum G; Beck BB
Am J Kidney Dis; 2011 Sep; 58(3):453-5. PubMed ID: 21705122
[TBL] [Abstract][Full Text] [Related]
9. Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes.
Sidhu H; Allison MJ; Chow JM; Clark A; Peck AB
J Urol; 2001 Oct; 166(4):1487-91. PubMed ID: 11547118
[TBL] [Abstract][Full Text] [Related]
10. Oxalobacter formigenes treatment confers protective effects in a rat model of primary hyperoxaluria by preventing renal calcium oxalate deposition.
Verhulst A; Dehmel B; Lindner E; Akerman ME; D'Haese PC
Urolithiasis; 2022 Apr; 50(2):119-130. PubMed ID: 35122487
[TBL] [Abstract][Full Text] [Related]
11. Oxalobacter formigenes: Opening the door to probiotic therapy for the treatment of hyperoxaluria.
Jairath A; Parekh N; Otano N; Mishra S; Ganpule A; Sabnis R; Desai M
Scand J Urol; 2015; 49(4):334-7. PubMed ID: 25645091
[TBL] [Abstract][Full Text] [Related]
12. Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria.
Sidhu H; Hoppe B; Hesse A; Tenbrock K; Brömme S; Rietschel E; Peck AB
Lancet; 1998 Sep; 352(9133):1026-9. PubMed ID: 9759746
[TBL] [Abstract][Full Text] [Related]
13. Urinary oxalate excretion in urolithiasis and nephrocalcinosis.
Neuhaus TJ; Belzer T; Blau N; Hoppe B; Sidhu H; Leumann E
Arch Dis Child; 2000 Apr; 82(4):322-6. PubMed ID: 10735843
[TBL] [Abstract][Full Text] [Related]
14. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.
Sidhu H; Schmidt ME; Cornelius JG; Thamilselvan S; Khan SR; Hesse A; Peck AB
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S334-40. PubMed ID: 10541258
[TBL] [Abstract][Full Text] [Related]
15. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
Troxel SA; Sidhu H; Kaul P; Low RK
J Endourol; 2003 Apr; 17(3):173-6. PubMed ID: 12803990
[TBL] [Abstract][Full Text] [Related]
16. Oxalobacter formigenes colonization normalizes oxalate excretion in a gastric bypass model of hyperoxaluria.
Canales BK; Hatch M
Surg Obes Relat Dis; 2017 Jul; 13(7):1152-1157. PubMed ID: 28552742
[TBL] [Abstract][Full Text] [Related]
17. Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.
Michael M; Groothoff JW; Shasha-Lavsky H; Lieske JC; Frishberg Y; Simkova E; Sellier-Leclerc AL; Devresse A; Guebre-Egziabher F; Bakkaloglu SA; Mourani C; Saqan R; Singer R; Willey R; Habtemariam B; Gansner JM; Bhan I; McGregor T; Magen D
Am J Kidney Dis; 2023 Feb; 81(2):145-155.e1. PubMed ID: 35843439
[TBL] [Abstract][Full Text] [Related]
18. Sel1-like proteins and peptides are the major
Arvans D; Chang C; Alshaikh A; Tesar C; Babnigg G; Wolfgeher D; Kron S; Antonopoulos D; Bashir M; Cham C; Musch M; Chang E; Joachimiak A; Hassan H
Am J Physiol Cell Physiol; 2023 Jul; 325(1):C344-C361. PubMed ID: 37125773
[TBL] [Abstract][Full Text] [Related]
19. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.
Tavasoli S; Alebouyeh M; Naji M; Shakiba Majd G; Shabani Nashtaei M; Broumandnia N; Basiri A
BJU Int; 2020 Jan; 125(1):133-143. PubMed ID: 31145528
[TBL] [Abstract][Full Text] [Related]
20. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
Hoppe B; von Unruh GE; Blank G; Rietschel E; Sidhu H; Laube N; Hesse A
Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
